The duty to disclose adverse clinical trial results.
Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results...
Үндсэн зохиолчид: | Liao, S, Sheehan, M, Clarke, S |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2009
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Disclosing clinical trial results: publicity, significance and independence.
-н: Liao, S, зэрэг
Хэвлэсэн: (2009) -
Randomization should be disclosed to potential research subjects.
-н: Binik, A, зэрэг
Хэвлэсэн: (2013) -
Comparative Study of Securities issuer's affirmative duty to disclose information
in Iranian and American Law
-н: Morteza Shahidi, зэрэг
Хэвлэсэн: (2020-04-01) -
Press releases for Phase 2 clinical trial topline results: Have the objective pre-specified efficacy results been disclosed?
-н: Zheng Su, зэрэг
Хэвлэсэн: (2016-12-01) -
HIV/AIDS, TO DISCLOSE OR NOT TO DISCLOSE: THAT IS THE QUESTION
-н: Andra le Roux-Kemp
Хэвлэсэн: (2013-04-01)